<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250122064481N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-01-24</date_registration>
      <primary_sponsor>Shiraz University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the effect of acupuncture versus mesotherapy in the treatment of tennis elbow compared to the control group (oral medication and splinting alone)</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the effect of acupuncture versus mesotherapy in the treatment of tennis elbow compared to the control group (oral medication and splinting alone)</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-02-19</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>54</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/81469</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: The differences of opinion among the treatment methods for tennis elbow and the lack of a study comparing the effect of mesotherapy and acupuncture against the control group in the treatment of these patients, due to the safety and low cost of these two treatment methods and the absence of side effects Other treatment methods such as side effects caused by corticosteroid injection, this study was conducted with the aim of comparing these treatment methods, Randomization description: Randomization:
The random allocation method in this study will be the permutation block method of 6 such that A represents the person who receives intervention 1, B represents the person who receives intervention 2, and C represents the person who is placed in the control group.
How to hide the allocation of participants:
1. A______________________________________
2. C______________________________________
3. C______________________________________
4. C______________________________________
5. A______________________________________
6. B______________________________________
7. B______________________________________
8. B______________________________________
9. C______________________________________
10. A______________________________________
11. B______________________________________
12. C______________________________________
13. C______________________________________
14. B______________________________________
15. A______________________________________
16. A______________________________________
17. A______________________________________
18. B______________________________________
19. B______________________________________
20. B______________________________________
21. C______________________________________
22. A______________________________________
23. B______________________________________
24. A______________________________________
25. B______________________________________
26. C______________________________________
27. A______________________________________
28. C______________________________________
29. A______________________________________
30. A______________________________________
31. B______________________________________
32. C______________________________________
33. A______________________________________
36. C______________________________________
35. C______________________________________
36. B______________________________________
37. B______________________________________
38. B______________________________________
39. C______________________________________
40. A______________________________________
41. C______________________________________
42. B______________________________________
43. B______________________________________
44. A______________________________________
45. C______________________________________
46. A______________________________________

47. A______________________________________
48. C______________________________________
49. B______________________________________
50. A______________________________________
51. A______________________________________
52. C______________________________________
53. B______________________________________
54. C______________________________________
In order to hide the random sequence method, another person who is unaware of the research process is provided, and the questionnaires are completed by a person who is unaware of the division of the groups.</study_design>
      <phase>3</phase>
      <hc_freetext>Tennis elbow.</hc_freetext>
      <i_freetext>Intervention 1: The first intervention group: to perform mesotherapy with piroxicam, we insert the needle into the skin at an angle of 10 degrees and horizontally. The needle entry point is the acupuncture points Lu5, Li10, Li11, Li12 and the maximum tenderness point, which is composed of one cc of piroxicam 20 mg. And 4 cc of 2% lidocaine is used in each point with a depth of one to three millimeters and on two occasions of 0 and 7 days. Injections are performed using 5 cc disposable sterile syringes with a thin needle head (0.27 mm x 4 mm).Stretching exercises (for two weeks) and strengthening of wrist extensors (after two weeks) are used. The duration of each exercise is 15 to 30 seconds and is repeated 10 to 30 times a day according to the patient's tolerance. Intervention 2: The second intervention group: A special acupuncture needle with a size of 13 x 18 cm is used to perform acupuncture. The needle entry point is the acupuncture points Lu5, Li10, Li11, Li12 and points with maximum tenderness. The depth of needle insertion is selected according to the recommendations of traditional Chinese acupuncture for classic points and the needles are removed after 25 minutes. Acupuncture sessions are performed for 4 weeks and between 2 to 3 sessions per week (on average, each patient has at least 10 sessions during He is treated with acupuncture for 4 weeks.Stretching exercises (for two weeks) and strengthening of wrist extensors (after two weeks) are used. The duration of each exercise is 15 to 30 seconds and is repeated 10 to 30 times a day according to the patient's tolerance. Intervention 3: Control group: Oral naproxen tablets of 500 mg are used twice a day (once every twelve hours) for a period of 7 days.Stretching exercises (for two weeks) and strengthening of wrist extensors (after two weeks) are used. The duration of each exercise is 15 to 30 seconds and is repeated 10 to 30 times a day according to the patient's tolerance.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The results of completing the questionnaires on improving pain and function are published without mentioning the names and personal information of the patients.

When:
The access period starts after the results are printed

To whom:
Only for researchers working in academic and scientific institutions

Conditions:
Only data analysis in terms of quality of life improvement in tennis elbow patients is allowed.

Where to obtain:
malekmohammadi@sums.ac.ir

How to obtain:
3 to 6 months after receiving the applicant's email

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mahshid Malekmohamadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.6 Eram dormitory.,Eram square.,Shiraz</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7194685791</zip>
        <telephone>+98 34 3261 1443</telephone>
        <email>malekmohammadi@sums.ac.ir</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mahshid Malekmohamadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.6 Eram dormitory.,Eram square.,Shiraz</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7194685791</zip>
        <telephone>+98 34 3261 1443</telephone>
        <email>malekmohammadi@sums.ac.ir</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Completing and signing the consent form
Clinical diagnosis of tennis elbow in the form of pain in the external epicondyle region of the humerus bone by local pressure and wrist extension against resistance
Age between 25 and 70 years
At least 3 months have passed since the onset of symptoms
They have not responded to primary and conservative treatments</inclusion_criteria>
      <agemin>25 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Any clinical symptoms of effusion, inflammation, redness and warmth of the involved area
Having uncontrolled diabetes, rheumatic diseases and vascular collagen, myopathy, any serious systemic and local infection, Brucella, bleeding diseases
History of surgery in the elbow joint of the affected side
Severe deformity of the upper limbs
Inability to communicate and complete questionnaires
History of allergies and allergic reactions to the drugs used, history of significant liver, kidney, brain and cardiopulmonary disorders, history of injections in or around the affected joint in the last 3 months, history of elbow and upper limb physiotherapy in the last 1 month
Stable use of NASID in the last 48 hours
Pregnant and lactating women, people with cancer
People who are using anticoagulants</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M77.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Lateral epicondylitis</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The first intervention group: to perform mesotherapy with piroxicam, we insert the needle into the skin at an angle of 10 degrees and horizontally. The needle entry point is the acupuncture points Lu5, Li10, Li11, Li12 and the maximum tenderness point, which is composed of one cc of piroxicam 20 mg. And 4 cc of 2% lidocaine is used in each point with a depth of one to three millimeters and on two occasions of 0 and 7 days. Injections are performed using 5 cc disposable sterile syringes with a thin needle head (0.27 mm x 4 mm).Stretching exercises (for two weeks) and strengthening of wrist extensors (after two weeks) are used. The duration of each exercise is 15 to 30 seconds and is repeated 10 to 30 times a day according to the patient's tolerance.</i_keyword>
      <i_keyword>The second intervention group: A special acupuncture needle with a size of 13 x 18 cm is used to perform acupuncture. The needle entry point is the acupuncture points Lu5, Li10, Li11, Li12 and points with maximum tenderness. The depth of needle insertion is selected according to the recommendations of traditional Chinese acupuncture for classic points and the needles are removed after 25 minutes. Acupuncture sessions are performed for 4 weeks and between 2 to 3 sessions per week (on average, each patient has at least 10 sessions during He is treated with acupuncture for 4 weeks.Stretching exercises (for two weeks) and strengthening of wrist extensors (after two weeks) are used. The duration of each exercise is 15 to 30 seconds and is repeated 10 to 30 times a day according to the patient's tolerance.</i_keyword>
      <i_keyword>Control group: Oral naproxen tablets of 500 mg are used twice a day (once every twelve hours) for a period of 7 days.Stretching exercises (for two weeks) and strengthening of wrist extensors (after two weeks) are used. The duration of each exercise is 15 to 30 seconds and is repeated 10 to 30 times a day according to the patient's tolerance.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Intensity of pain. Timepoint: Before starting the treatment and 2 and 4 weeks after the treatment. Method of measurement: Visual Analog Scale.</prim_outcome>
      <prim_outcome>Performance. Timepoint: Before starting the treatment and 2 and 4 weeks after the treatment. Method of measurement: Patient-Rated Tennis Elbow Evaluation.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shiraz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-01-20</approval_date>
        <contact_name>Ethics Committee of Shiraz University of Medical Sciences</contact_name>
        <contact_address>No.6 Eram  dormitory, Eram square Shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
